期刊文献+

三阴乳腺癌的治疗 被引量:3

Treatment of triple negative breast cancer
原文传递
导出
摘要 三阴乳腺癌(TNBC)是乳腺癌中的一个特殊类型,其特殊的临床病理特征及分子表达类型使TNBC的治疗成为国际难题。近年来,研究者对TNBC的治疗进行的各种尝试及探索已初具成效,这为TNBC的治疗提供了方向,也为TNBC患者提供了希望。 Triple negative breast cancer (TNBC) is a special type of breast cancer. Its special clinical pathological characteristic and molecule expression type make the treatment of TNBC become an international problem. In recent years, a variety of attempts and explorations to the treatment of TNBC have made some ini- tial results, which provides a direction for the treatment of TNBC and offers hope for the patients with TNBC.
出处 《国际肿瘤学杂志》 CAS 2013年第9期681-684,共4页 Journal of International Oncology
关键词 乳腺肿瘤 综合疗法 三阴 Breast neoplasms Combined modality therapy Triple-negative
  • 相关文献

参考文献24

  • 1Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: corre-lation between MR imaging and pathologic findings. Radiology,2009,250(3):638-647. 被引量:1
  • 2Yamamoto Y, Ibusuki M, Nakano M,et al. Clinical significance ofbasal-like subtype in triple-negative breast cancer. Breast Cancer,2009,16(4):260-267. 被引量:1
  • 3Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancerdefined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Hes, 2008 , 14(5) : 1368-1376. 被引量:1
  • 4Lee EY. Promotion of BRCA1 -associated triple-negative breast cancerby ovarian hormones. Curr Opin Obstet Gynecol, 2008, 20( 1) :68-73. 被引量:1
  • 5Voduc KD,Cheang MC, Tyldesley S, et al. Breast cancer subtypesand the risk of local and regional relapse. J Clin Oncol, 2010,28(10):1684-1691. 被引量:1
  • 6Iwata H,Sato N,Masuda N, et al. Docetaxel followed by fluoroura-cil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy forpa-tients with primary breast cancer. Jpn J Clin Oncol, 2011,41(7):867-875. 被引量:1
  • 7Masuda H, Masuda N,Kodama Y,et al. Predictive factors for the ef-fectiveness of neoadjuvant chemotherapy and prognosis in triple-nega-tive breast cancer patients. Cancer Chemother Pharmacol, 2011,67(4);911-917. 被引量:1
  • 8Stefansson OA,Jonasson JG,Olafsdottir K,et al. CpG island hyper-methylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer. Epigenetics, 2011,6(5) :638-649. 被引量:1
  • 9Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvanttherapy and long-term survival in patients with triple-negative breastcancer. J Clin Oncol,2008, 26(8) :1275-1281. 被引量:1
  • 10Kennedy CR, Gao F, Margenthaler JA. Neoadjuvant versus adjuvantchemotherapy for triple negative breast cancer. J Surg Res, 2010,163(1) :52-57. 被引量:1

二级参考文献17

  • 1王潇潇,周中梅,袁中玉,张东生,史艳侠,姜文奇.多西紫杉醇联合卡培他滨治疗转移性乳腺癌的临床研究[J].癌症,2007,26(4):407-410. 被引量:21
  • 2Bauer KR, Brown M, Cress RD ,et al. Descriptive analysis of estrogen receptor( ER ) -Negative, progesterone receptor ( PR ) -negative, and HER2- negative invasive breast cancer, the socalled triple-negative phenotype:a population-based study from the california cancer registry [J]. Cancer,2007 ; 109 ( ) : 1721-8. 被引量:1
  • 3Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nat Med, 1995 ; 1 ( 1 ) :27-31. 被引量:1
  • 4袁霞,张东生,袁中玉,何樱,马慧敏,李俊,姜文奇.恩度联合化疗在HER-2阴性乳腺癌肝转移中的临床应用——附5例报告[J].癌症进展,2007,5(6):604-607. 被引量:17
  • 5RAKHA E A,REIS FILHO J S,ELLIS I O. Basal-like breast cancer:a critical review[J].Journal of Clinical Oncology,2008,(15):2568-2581.doi:10.1200/JCO.2007.13.1748. 被引量:1
  • 6SCHNEIDER B P,WINER E P,FOULKES W D. Triple-negative breast cancer:risk factors to potential targets[J].Clinical Cancer Research,2008,(24):8010-8018.doi:10.1158/1078-0432.CCR-08-1208. 被引量:1
  • 7TURNER N,TUTT A,ASHWORTH A. Hallmarks of 'BRCAness' in sporadic cancers[J].Nature Reviews Cancer,2004,(10):814-819. 被引量:1
  • 8GOLDHIRSCH A,WOOD W C,COATES A S. Strategies for subtypes--dealing with the diversity of breast cancer:highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J].Annals of Oncology,2011,(08):1736-1747. 被引量:1
  • 9BYRSKI T,HUZARSKI T,DENT R. Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients[J].Breast Cancer Research and Treatment,2009,(02):359-363.doi:10.1007/s10549-008-0128-9. 被引量:1
  • 10SILVER D P,RICHARDSON A L,EKLUND A C. Efficacy of neoadjuvant cisplatin in triple-negative breast cancer[J].Journal of Clinical Oncology,2010,(07):1145-1153.doi:10.1200/JCO.2009.22.4725. 被引量:1

共引文献28

同被引文献23

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部